ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Up 104.3% in January

ASP Isotopes Inc. (NASDAQ:ASPI) saw a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 15,300,000 shares, a growth of 104.3% from the January 15th total of 7,490,000 shares. Based on an average daily volume of 3,810,000 shares, the short-interest ratio is currently 4.0 days. Approximately 28.2% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group reiterated a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a research note on Friday, October 18th.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Fiera Capital Corp bought a new stake in ASP Isotopes during the 3rd quarter worth about $723,000. GSA Capital Partners LLP grew its position in shares of ASP Isotopes by 96.0% during the 3rd quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock worth $2,143,000 after buying an additional 377,721 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in shares of ASP Isotopes during the third quarter worth approximately $6,249,000. Charles Schwab Investment Management Inc. lifted its holdings in ASP Isotopes by 16.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after buying an additional 17,159 shares during the period. Finally, Telemark Asset Management LLC bought a new position in ASP Isotopes in the third quarter valued at approximately $4,726,000. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Price Performance

Shares of ASPI stock opened at $5.29 on Friday. ASP Isotopes has a 1 year low of $1.86 and a 1 year high of $9.33. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The firm’s 50 day moving average is $5.26 and its 200-day moving average is $4.46.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.